公告编号：2023-046 康普化学 证券代码 : 834033 重庆康普化学工业股份有限公司 2023 年第一季度报告 1 公告编号：2023-046 第一节 重要提示 公司董事、监事、高级管理人员保证本报告所载资料不存在虚假记载、误导性陈述或者重大遗漏，并对 其内容的真实性、准确性和完整性承担个别及连带责任。 公司负责人邹潜、主管会计工作负责人吴成刚及会计机构负责人（会计主管人员）吴成刚保证季 度报告中财务报告的真实、准确、完整。 本季度报告未经会计师事务所审计。 本季度报告涉及未来计划等前瞻性陈述，不构成公司对投资者的实质承诺，投资者及相关人士均应 对此保持足够的风险认识，并且应当理解计划、预测与承诺之间的差异。 | 事项 | | 是或否 | | --- | --- | --- | | 是否存在公司董事、监事、高级管理人员对季度报告内容存在异议或无法保证其真 | □是 | √否 | | 实、准确、完整 | | | | 是否存在未出席董事会审议季度报告的董事 | □是 | √否 | | 是否存在未按要求披露的事项 | □是 | √否 | | 是否审计 | □是 | √否 | | 是否被出具非标准审计意见 ...

证券代码：834033 证券简称：康普化学 公告编号：2023-033 重庆康普化学工业股份有限公司 2022 年年度业绩说明会预告公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假 记载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承 担个别及连带法律责任。 三、 参加人员 公司董事长：邹潜先生 公司董事会秘书：张渝先生 公司财务负责人：吴成刚先生 公司保荐代表人：陈志先生、张维先生 四、 投资者参加方式 本次说明会采用网络方式召开。 一、 说明会类型 重庆康普化学工业股份有限公司（以下简称"公司"）已于 2023 年 3 月 15 日在北京证券交易所指定信息披露平台（http://www.bse.cn/）披露《2022 年年度报告》（公告编号：2023-019），为便于广大投资者更深入全面地了解公 司情况，加强与投资者的互动交流，公司将召开 2022 年年度网上业绩说明会。 二、 说明会召开的时间、地点 （一）会议召开时间：2023 年 4 月 3 日（星期一）下午 3:00 至 5:00。 （二）会议召开地点 本次业绩说明会将采用网络远程的方式举行，投资者可登录全景网"投 ...

Financial Performance - The total revenue for 2022 was CNY 350,081,017.45, representing a 55.44% increase compared to CNY 225,215,143.82 in 2021[38]. - The net profit attributable to shareholders for 2022 was CNY 104,049,793.46, a 104.22% increase from CNY 50,950,587.72 in 2021[38]. - The total assets as of the end of 2022 amounted to CNY 724,827,590.72, a 129.82% increase from CNY 315,392,434.09 at the end of 2021[40]. - The total liabilities at the end of 2022 were CNY 217,070,541.76, reflecting a 125.01% increase from CNY 96,473,080.06 at the end of 2021[40]. - The company’s cash flow from operating activities for 2022 was CNY 75,233,927.84, a 147.68% increase compared to CNY 30,375,595.03 in 2021[42]. - The company’s basic earnings per share for 2022 was CNY 1.40, up 105.88% from CNY 0.68 in 2021[38]. - The company’s weighted average return on equity for 2022 was 39.86%, compared to 26.38% in 2021[38]. - The company’s inventory turnover rate for 2022 was 2.22, slightly up from 2.17 in 2021[43]. - The operating profit for 2022 was ¥119,745,655.44, a 104.47% increase from ¥58,564,159.53 in 2021, primarily due to increased sales[70]. Share Capital and Dividends - The company completed a rights distribution on May 31, 2022, distributing cash dividends of RMB 17.1675 million and issuing 17.1675 million new shares, increasing total shares from 57.225 million to 74.3925 million[6]. - The company successfully listed on the Beijing Stock Exchange on December 21, 2022, issuing 17.25 million shares and raising approximately RMB 255 million, resulting in a total share capital of 91.6425 million[7]. - The total share capital increased from 57,225,000 shares to 89,392,500 shares following a public offering of 15,000,000 shares[199]. - The company distributed cash dividends totaling CNY 17,167,500 and issued 17,167,500 shares as stock dividends, resulting in a total share capital increase[199]. Investment and Projects - The company has invested RMB 176.82 million in fixed and intangible assets for its new projects, which could impact future profits if expected returns are not realized[15]. - The company is constructing a project to produce 20,000 tons of specialty surfactants, expected to be completed by Q3 2023, which will increase annual production capacity from 5,000 tons to 20,000 tons[15]. - The company plans to enhance its profitability and product development capabilities through the "20,000 tons of special surfactants construction project" and the "Kangpu Chemical Technology Research Institute" fundraising project[118]. - The company is currently engaged in multiple construction projects, including a new production line and a research institute, with ongoing investments totaling ¥27,250,335.37[89]. Market and Sales - A significant sales contract was signed with Shanghai Donghe Trading Co., which is expected to positively impact the company's business development and brand effect[8]. - The company exports its products to major copper mining companies globally, including BHP, CODELCO, and Glencore, and has established a strong market position[55]. - The company experienced a decrease in foreign sales revenue, while domestic sales increased due to changes in procurement practices by clients[80]. - Major clients accounted for 58.65% of total sales, with the top client contributing ¥96,849,557.64, or 27.69% of total sales[82]. Risks and Challenges - The company faces risks related to product technology iteration, as advancements in metallurgy and environmental applications require continuous innovation to maintain competitiveness[14]. - The company’s profitability may be affected by fluctuations in raw material prices, particularly those linked to international oil prices, which could lead to decreased gross margins if costs rise significantly[14]. - The company’s export business is subject to risks from international trade policies and potential sanctions that could affect sales performance in foreign markets[15]. - The company faces potential tax burden increases if national tax policies change, which could negatively impact profitability[16]. - The company is exposed to exchange rate risks, particularly with a significant portion of exports, which could impact net profit if the USD/RMB exchange rate declines[16]. - The company has identified various risks, including technical, operational, internal control, and potential misuse of control by actual controllers, which could affect governance and decision-making[17]. Research and Development - The company has established a comprehensive technical research and development system and has received multiple patents and honors, including recognition as a "High-tech Enterprise" and "Specialized, Refined, Characteristic, and Innovative" enterprise at the provincial level[56][58]. - The company is actively involved in the research and development of new energy battery metal extractants, which are crucial for the growing electric vehicle market[54]. - Research and development expenses rose by 44.54% to ¥11,463,638.02, driven by increased investment in R&D projects[73]. - The total number of R&D personnel increased from 34 to 51, with the proportion of R&D staff in total employees rising from 15.04% to 16.94%[101]. Corporate Governance and Compliance - The company is committed to protecting the rights of shareholders, especially minority shareholders, in its operations[140]. - The company has made commitments to avoid occupying company funds and to not engage in related party transactions[144]. - The company will publicly disclose reasons for any failure to fulfill commitments and apologize to shareholders and the public[188]. - The controlling shareholder has committed to voting in favor of profit distribution proposals that comply with the company's articles of association[186]. Environmental and Safety Management - Environmental protection remains a priority, with potential increased costs due to stricter regulations, impacting short-term profitability but benefiting long-term sustainability[18]. - The company has established an EHS department to manage safety, but risks of accidents due to operational errors or natural disasters still exist[18]. - The company emphasizes a "green chemistry" development philosophy, focusing on energy-saving and environmentally friendly production processes[57].

本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 特别提示：本公告所载 2022 年年度主要财务数据为初步核算数据，未经会 计师事务所审计，具体数据以公司 2022 年年度报告中披露的数据为准，提请投 资者注意投资风险。 一、2022 年年度主要财务数据和指标 单位：元 | 项目 | 本报告期 | 上年同期 | 变动比例% | | --- | --- | --- | --- | | 营业收入 | 350,081,017.45 | 225,215,143.82 | 55.44% | | 归属于上市公司股东的净 | 104,085,184.82 | 50,950,587.72 | 104.29% | | 利润 | | | | | 归属于上市公司股东的扣 | 101,101,136.53 | 48,694,769.49 | 107.62% | | 除非经常性损益的净利润 | | | | | 基本每股收益 | 1.40 | 0.89 | 57.30% | | 加权平均净资产收益率% | 39.90% | 26.3 ...